- All sections
- G - Physics
- G01N - Investigating or analysing materials by determining their chemical or physical properties
- G01N 33/94 - Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics
Patent holdings for IPC class G01N 33/94
Total number of patents in this class: 1181
10-year publication summary
|
85
|
120
|
141
|
124
|
145
|
126
|
107
|
122
|
84
|
30
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Janssen Pharmaceutica N.V. | 3839 |
28 |
| Hound Labs, Inc. | 61 |
26 |
| Northern Bank Limited | 69 |
19 |
| F. Hoffmann-La Roche AG | 7958 |
16 |
| Quest Diagnostics Investments Incorporated | 432 |
15 |
| Psychemedics Corporation | 18 |
14 |
| Labrador Diagnostics LLC | 287 |
14 |
| The Regents of the University of California | 18943 |
13 |
| ARK Diagnostics, Inc. | 30 |
13 |
| The Florida International University Board of Trustees | 548 |
13 |
| Roche Diagnostics GmbH | 2745 |
11 |
| Becton, Dickinson and Company | 6712 |
11 |
| Siemens Healthcare Diagnostics Inc. | 1946 |
11 |
| Betterlife Pharma US Inc. | 12 |
10 |
| Roche Diagnostics Operations, Inc. | 1375 |
8 |
| MERZ PHARMA GmbH & CO. KGaA | 624 |
8 |
| Biomadison, Inc. | 48 |
7 |
| Laboratory Corporation of America Holdings | 655 |
7 |
| Prometheus Laboratories Inc. | 91 |
7 |
| Guardian Health, Inc. | 99 |
7 |
| Other owners | 923 |